Maybe, in a couple years, if the FDA decides the higher rate of side
effects is worth it. Other PIs have been shown to have serious cardio side
effects, so, hopefully, the testing will be thorough
Then there's Albuferon, a form of IFN that lasts longer and only has to be dosed aprox half as long. They have been trying to figure out the optimum dosing schedule for about five years now.